Search results for "Erythrocyte Aggregation"

showing 10 items of 25 documents

Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancer.

2004

Oxygenation of tumor tissue has recently been assed an important prerequisite for the effectiveness of radiotherapy in cervical cancer. Hyperviscosity is a common phenomenon in malignancy and a cause of reduced oxygen transport capacity that would favour tissue hypoxia. Hemorheological variables were serially tested preoperatively, during four cycles of fractionated adjuvant IR192 HDR after loading radiation (HDR-AL) of the vaginal vault (weekly intervals), and 6 months postoperatively in patients with cervical (n=12) and endometrial cancer (n=26). Women who were scheduled for benign tumor surgery served as controls (n=29). Preoperatively, in cervical and endometrial cancer patients, mean …

0301 basic medicineErythrocyte Aggregationmedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyUrologyUterine Cervical Neoplasms030204 cardiovascular system & hematologyHysterectomy03 medical and health sciencesLeukocyte Count0302 clinical medicineUterine cancermedicineHumansAgedCervical cancerbusiness.industryPlatelet CountEndometrial cancerOxygen transportFibrinogenHematologyGeneral MedicineMiddle Agedmedicine.diseaseBlood ViscosityCombined Modality TherapyCell HypoxiaSurgeryEndometrial NeoplasmsRadiation therapy030104 developmental biologyHemorheologyVaginal vaultFemaleRadiotherapy AdjuvantbusinessBiomarkersClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Rheological blood behavior is not only influenced by cardiovascular risk factors but also by aging itself. Research into 927 healthy Spanish Mediterr…

2013

It is not well-established whether the alterations that the hemorheological profile undergoes with aging are an effect of concomitant cardiovascular risk factors or are due to age itself. To clarify this issue, we investigated the effect of age on blood rheology in a population of 927 healthy subjects from eastern Spain aged between 16-85 years, divided into four age groups (<30, 30-44, 45-50, ≥60 years) with and without cardiovascular risk factors. We determined blood viscosity, corrected blood viscosity (BVc), plasma viscosity (PV), erythrocyte aggregation (EA), erythrocyte deformability (EEI60) and fibrinogen, along with glucose and plasma lipids. We found that corrected blood viscosity …

AdultBlood GlucoseErythrocyte AggregationMalemedicine.medical_specialtyAgingAdolescentPhysiologyBlood viscosityPopulationFibrinogenLogistic regressionErythrocyte aggregationYoung AdultRisk FactorsPhysiology (medical)Internal medicineMedicineErythrocyte deformabilityHumanseducationMean corpuscular volumeAgedAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryAge FactorsFibrinogenHematologyMiddle AgedLipidsEndocrinologyCardiovascular DiseasesSpainConcomitantImmunologyHemorheologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugClinical hemorheology and microcirculation
researchProduct

Diabetes mellitus: mean erythrocyte aggregation, glycometabolic pattern, red cell Ca2+ content, and erythrocyte membrane dynamic properties.

1993

AdultBlood GlucoseErythrocyte Aggregationmedicine.medical_specialtyErythrocytesAdolescentMembrane Fluiditychemistry.chemical_elementCalciumBiochemistryErythrocyte aggregationBlood cellInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansChildAgedRed Cellbusiness.industryErythrocyte MembraneCell BiologyMetabolismMiddle Agedmedicine.diseaseErythrocyte membraneRed blood cellEndocrinologymedicine.anatomical_structurechemistryCalciumCardiology and Cardiovascular MedicinebusinessMicrovascular research
researchProduct

Haemorheological parameters in young patients with acute myocardial infarction

2008

The role played by hemorheological alterations on acute myocardial infarction (AMI) in young patients remains a question of debate. We have carried out a case-control study of 84 AMI patients aged45 years and 135 sex and age matched controls, in which blood viscosity (BV), plasma viscosity (PV), erythrocyte aggregation (EA) performed with the Myrenne (EA0, EA1) and the Sefam aggregometer (Ta, AI10, gammaD), erythrocyte deformability (ED) along with fibrinogen (Fbg), C-reactive protein (CRP) and plasmatic lipids i.e. total cholesterol (T-Chol) and triglycerides (TG) were determined. AMI patients showed higher, Fbg, TG, EA0, EA1, IA10, gammaD and lower Ta than controls (p=0.029, p0.001, p=0.0…

AdultErythrocyte AggregationMaleRiskmedicine.medical_specialtyErythrocytesPhysiologyBlood viscosityMyocardial InfarctionErythrocyte aggregationErythrocyte DeformabilityPhysiology (medical)Internal medicineHumansMedicineErythrocyte deformabilityMyocardial infarctionbusiness.industryCase-control studyFibrinogenHematologyMiddle AgedBlood Viscositymedicine.diseaseC-Reactive ProteinCase-Control StudiesHemorheologyCardiologyPhysical therapyFemaleCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Erythrocyte Membrane Phosphatidylserine Exposure in Obesity

2008

It has been suggested that increased erythrocyte membrane phosphatidylserine (PS) exposure could contribute to hypercoagulability and hemorheological disturbances in obesity. The aim of our study was to evaluate PS exposure in obese patients and in a control group and to correlate this with hemorheological properties, i.e., erythrocyte aggregability (EA) and deformability, and to evaluate the effect of weight loss on these parameters. An anthropometric and analytical evaluation was performed at baseline and after 3 months on a diet (very low-calorie diet for 4 weeks and low-calorie diet for 2 months) on 49 severe or morbid obese patients (37 women, 12 men) and 55 healthy volunteers (39 wome…

AdultErythrocyte AggregationMalemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Phosphatidylserinesmedicine.disease_causeErythrocyte aggregationFlow cytometrychemistry.chemical_compoundYoung AdultEndocrinologyWeight lossInternal medicineErythrocyte DeformabilityMalondialdehydeWeight LossMedicineErythrocyte deformabilityHumansObesityProtein PrecursorsNutrition and Dieteticsmedicine.diagnostic_testbusiness.industryErythrocyte MembranePhosphatidylserineMiddle AgedMalondialdehydePathophysiologyPeptide FragmentsOxidative StressEndocrinologychemistryCase-Control StudiesImmunologyFemaleProthrombinmedicine.symptombusinessOxidative stress
researchProduct

Erythrocyte aggregation in homozygous sickle cell disease

2014

Amparo Vayaa,∗, Susana Colladoa, Rafael Alisb,c and Maria-Angeles Dasid aHemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain bResearch Universitary Institute “Dr. Vina Giner”, Molecular and Mitochondrial Medicine, Catholic University of Valencia, “San Vicente Martir”, Valencia, Spain cFaculty of Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain dPediatry Service, La Fe University Hospital, Valencia, Spain

AdultErythrocyte AggregationMalemedicine.medical_specialtyAdolescentbiologyPhysiologybusiness.industryAnemia Sickle CellHematologybiology.organism_classificationUniversity hospitalYoung AdultChild PreschoolPhysiology (medical)Family medicineHumansMedicineFemaleChildCardiology and Cardiovascular MedicinebusinessValenciaClinical Hemorheology and Microcirculation
researchProduct

Metabolic alterations in morbid obesity. Influence on the haemorheological profile.

2011

There are few studies on haemorheological disturbances in morbidly obese patients. The role played by the metabolic syndrome on the rheological profile of morbidly obese subjects has not yet been established, and it is not clear whether morbidly obese, but "metabolically healthy", show rheological alterations. We aimed to determine the whole rheological profile in 136 morbidly obese patients and 136 normo-weight volunteers, along with plasma lipids, inflammatory and insulin resistance parameters. Patients had statistically higher glucose, triglycerides, HbA1c, leptin, insulin, HOMA, CRP, leucocytes, fibrinogen, plasma viscosity (p0.001, respectively), erythrocyte aggregation at 3 s-1 (p = 0…

AdultErythrocyte AggregationMalemedicine.medical_specialtyPhysiologymedicine.medical_treatmentInflammationFibrinogenErythrocyte aggregationBody Mass IndexInsulin resistancePhysiology (medical)Internal medicinemedicineHumansBlood CoagulationMetabolic Syndromebusiness.industryInsulinLeptinBody WeightHematologymedicine.diseaseBlood ViscosityObesityObesity MorbidEndocrinologyHemorheologyFemaleMetabolic syndromemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugClinical hemorheology and microcirculation
researchProduct

Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.

2007

It is not well established whether haemorheological alterations constitute independent risk factors for deep vein thrombosis (DVT).We have determined in 149 DVT patients and in 185 control subjects the body mass index (BMI), the haemorheological profile: blood viscosity (BV), plasma viscosity (PV), fibrinogen (Fg), erythrocyte aggregation (EA), erythrocyte deformability (ED) and plasma lipids. In the crude analysis BMI, Fg, PV, EA, triglycerides (TG) and ApoB were statistically higher and HDL cholesterol (HDL-Chol) statistically lower in DVT patients than in controls. No differences in BV and ED were observed.After BMI adjustment, Fg, PV and EA remained statistically higher in DVT cases tha…

AdultErythrocyte AggregationMalemedicine.medical_specialtyTime FactorsDeep veinBlood viscosityHyperlipidemiasFibrinogenGastroenterologyRisk AssessmentBody Mass IndexDeep vein thrombosis; Lipids; Obesity; HaemorheologyRisk FactorsInternal medicineDeep vein thrombosisErythrocyte DeformabilityOdds RatioMedicineHumanscardiovascular diseasesObesityRisk factorTriglyceridesUNESCO::CIENCIAS MÉDICAS ::Patología::TrombosisVenous Thrombosisbusiness.industryFibrinogenHematologyOdds ratioMiddle Agedmedicine.diseaseBlood ViscosityThrombosisLipidsSurgeryHaemorheologymedicine.anatomical_structureCholesterolCase-Control StudiesHemorheologyHemorheologyFemalebusinessBody mass index:CIENCIAS MÉDICAS ::Patología::Trombosis [UNESCO]medicine.drugThrombosis and haemostasis
researchProduct

Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia

2020

: In this case report, we examine the behavior of plasma viscosity, explored at high and low shear rates, and erythrocyte aggregation in two patients with congenital afibrinogenemia, a clinical disorder firstly described in 1920 and that has an estimated incidence of 1 : 1-200 0000. The two hemorheological parameters examined by us showed a marked decrease in both patients, in one of whom erythrocyte aggregation was even undetectable. Keeping in mind that spontaneous thrombosis (venous and arterial) has been often described in congenital afibrinogenemia, it can be hypothesized that the decrease in plasma viscosity and erythrocyte aggregation might cause a reduction of the endothelial synthe…

AdultErythrocyte Aggregationmedicine.medical_specialty030204 cardiovascular system & hematologyErythrocyte aggregationNitric oxidePlasmaYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineShear stressHumansPlasma viscositybusiness.industryPlasma viscosity afibrinogenemiaHematologyGeneral MedicineMiddle AgedAfibrinogenemiaBlood Viscositymedicine.diseaseCongenital afibrinogenemiaEndocrinologychemistryFemaleStress MechanicalbusinessSpontaneous thrombosis030215 immunology
researchProduct

Blood rheology during chemotherapy in patients with ovarian cancer.

1998

The use of platinum based chemotherapy in ovarian malignancy and other cancer types is known to be associated with deep vein thrombosis. In a prospective study of 47 patients with ovarian cancer of International Federation of Gynecology and Obstetrics stage Ib-IV, serial rheological parameters were determined (plasma viscosity, red blood cell aggregation under conditions of stasis and low shear) in addition to hemoglobin, hematocrit, leukocytes, platelets, and fibrinogen. At the same time the incidence of deep vein thrombosis was recorded before, during six cycles of first line cisplatinum/epirubicin/cyclophosphamide chemotherapy, and 2 months thereafter (two-months check-up). Only six pati…

AdultErythrocyte Aggregationmedicine.medical_specialtymedicine.drug_classDeep veinBlood viscosityVenographyLow molecular weight heparinAntineoplastic AgentsHematocritGastroenterologyHemoglobinsLeukocyte CountInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansProspective StudiesVeinCyclophosphamideAgedEpirubicinOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryPlatelet CountFibrinogenHematologyHeparin Low-Molecular-WeightMiddle AgedThrombophlebitismedicine.diseaseBlood ViscosityThrombosisSurgerymedicine.anatomical_structureHematocritHemorheologyFemaleCisplatinbusinessEpirubicinmedicine.drugThrombosis research
researchProduct